180 related articles for article (PubMed ID: 498587)
21. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
22. Control of immune complexes by the classical pathway.
Whaley K; Ahmed AE
Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
[TBL] [Abstract][Full Text] [Related]
23. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
Garred P; Michaelsen TE; Aase A; Mollnes TE
J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
[TBL] [Abstract][Full Text] [Related]
24. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
25. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
26. Chronic liver disease: the detection and characterization of circulating immune complexes.
Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
[TBL] [Abstract][Full Text] [Related]
27. [Immunologic study of pleural neoplastic effusions: Detection of immune complexes and complement activation].
Kaelin R; Docquier C; Lew D; Carpentier N; Lambert PH; Waldvogel FA
Schweiz Med Wochenschr; 1978 Dec; 108(49):1971-3. PubMed ID: 749195
[TBL] [Abstract][Full Text] [Related]
28. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
[TBL] [Abstract][Full Text] [Related]
29. Physicochemical and functional characterization of the C1r subunit of the first complement component.
Ziccardi RJ; Cooper NR
J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
[TBL] [Abstract][Full Text] [Related]
30. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
[TBL] [Abstract][Full Text] [Related]
31. Tumoricidal response following perfusion over immobilized protein A: identification of immunoglobulin oligomers in serum after perfusion and their partial characterization.
Balint J; Ikeda Y; Langone JJ; Shearer WT; Daskal I; Meek K; Cook G; Henry J; Terman DS
Cancer Res; 1984 Feb; 44(2):734-43. PubMed ID: 6607106
[TBL] [Abstract][Full Text] [Related]
32. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
Veerhuis R; van Es LA; Daha MR
Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
[TBL] [Abstract][Full Text] [Related]
33. The major circulating immunosuppressive activity in American visceral leishmaniasis patients is associated with a high-molecular weight fraction and is not mediated by IgG, IgG immune complexes or lipoproteins.
Soares NM; Ferraz TP; Nascimento EG; Carvalho EM; Pontes-de-Carvalho L
Microb Pathog; 2006 Jun; 40(6):254-60. PubMed ID: 16626930
[TBL] [Abstract][Full Text] [Related]
34. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
Shepherd PS
Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis.
Baughn RE; McNeely MC; Jorizzo JL; Musher DM
J Immunol; 1986 Feb; 136(4):1406-14. PubMed ID: 2418114
[TBL] [Abstract][Full Text] [Related]
36. The macromolecular structure of the first component of complement.
Assimeh SN; Painter RH
J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
[TBL] [Abstract][Full Text] [Related]
37. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
38. [Characterization of immune complexes in normal pregnancies].
Saito S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):391-400. PubMed ID: 3872337
[TBL] [Abstract][Full Text] [Related]
39. The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.
Wands JR; Mann E; Alpert E; Isselbacher KJ
J Clin Invest; 1975 May; 55(5):930-6. PubMed ID: 1123429
[TBL] [Abstract][Full Text] [Related]
40. Absence of a binding reactivity of human C-reactive protein for immunoglobulin or immune complexes.
Ballou SP; Macintyre SS
J Lab Clin Med; 1990 Mar; 115(3):332-8. PubMed ID: 2107267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
